c.1898C>G/p.Ser633Trp Mutation in Alpha-L-Iduronidase: Clinical and Structural Implications

Protein J. 2021 Feb;40(1):68-77. doi: 10.1007/s10930-020-09950-9. Epub 2021 Jan 2.

Abstract

Mucopolysaccharidosis type I is a rare autosomal recessive genetic disease caused by deficient activity of α-L-iduronidase. As a consequence of low or absent activity of this enzyme, glycosaminoglycans accumulate in the lysosomal compartments of multiple cell types throughout the body. Mucopolysaccharidosis type I has been classified into 3 clinical subtypes, ranging from a severe Hurler form to the more attenuated Hurler-Scheie and Scheie phenotypes. Over 200 gene variants causing the various forms of mucopolysaccharidosis type I have been reported. DNA isolated from dried blood spot was used to sequencing of all exons of the IDUA gene from a patient with a clinical phenotype of severe mucopolysaccharidosis type I syndrome. Enzyme activity of α-L-iduronidase was quantified by fluorimetric assay. Additionally, a molecular dynamics simulation approach was used to determine the effect of the Ser633Trp mutation on the structure and dynamics of the α-L-iduronidase. The DNA sequencing analysis and enzymatic activity shows a c.1898C>G mutation associated a patient with a homozygous state and α-L-iduronidase activity of 0.24 μmol/L/h, respectively. The molecular dynamics simulation analysis shows that the p.Ser633Trp mutation on the α-L-iduronidase affect significant the temporal and spatial properties of the different structural loops, the N-glycan attached to Asn372 and amino acid residues around the catalytic site of this enzyme. Low enzymatic activity observed for p.Ser633Trp variant of the α-L-iduronidase seems to lead to severe mucopolysaccharidosis type I phenotype, possibly associated with a perturbation of the structural dynamics in regions of the enzyme close to the active site.

Keywords: Alpha-L-iduronidase mutation; Hurler; Mucopolysaccharidosis; Structural dynamics.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abnormalities, Multiple / enzymology
  • Abnormalities, Multiple / genetics*
  • Abnormalities, Multiple / pathology
  • Abnormalities, Multiple / therapy
  • Catalytic Domain
  • Crystallography, X-Ray
  • Dermatan Sulfate / chemistry*
  • Dermatan Sulfate / metabolism
  • Enzyme Replacement Therapy / methods
  • Gene Expression
  • Heparitin Sulfate / chemistry*
  • Heparitin Sulfate / metabolism
  • Humans
  • Iduronidase / chemistry*
  • Iduronidase / genetics
  • Iduronidase / metabolism
  • Infant
  • Male
  • Molecular Dynamics Simulation
  • Mucopolysaccharidosis I / enzymology
  • Mucopolysaccharidosis I / genetics*
  • Mucopolysaccharidosis I / pathology
  • Mucopolysaccharidosis I / therapy
  • Point Mutation*
  • Principal Component Analysis
  • Protein Binding
  • Protein Conformation, alpha-Helical
  • Protein Conformation, beta-Strand
  • Protein Interaction Domains and Motifs
  • Substrate Specificity

Substances

  • Dermatan Sulfate
  • Heparitin Sulfate
  • Iduronidase